You can attend this radio show online or via telephone. Register to obtain the online link and call-in number.
Progress in understanding AML and developing therapies that treat this blood cancer is occurring at an astounding pace. In this radio show, Dr. James Blachly, an AML expert from the James Comprehensive Cancer Center at Ohio State University shares a broad overview of the latest treatments for all stages of AML: precursor conditions like MDS, newly diagnosed AML and relapsed/refractory AML. Dr. Blachly will discuss combination therapies, new immunotherapies, new diagnostic technologies and new targeted treatments that are being used in the clinic today and in development in AML clinical trials. Dr. Blachly will simplify the significant work being performed all over the world by dedicated researchers who have the goal of finding a cure for all patients with AML.
Hematologist oncologist, Member of the Leukemia Research Program at the OSUCCC, Assistant Professor of Biomedical Informatics and Internal Medicine at Ohio State University
Katie joined the HealthTree Foundation as the Community Director for AML in 2021. She is a registered dietitian who previously worked at the VA hospital in Dallas, Texas where she coached veterans with blood cancer on how to use nutrition to improve their treatment outcomes and minimize cancer-related side effects. Katie is passionate about health education and patient empowerment. In her spare time, she loves to experiment with new recipes in the kitchen, spend time running outdoors and travel to new places.
Thank you for your interest in the event. If you have any questions, we would love to help!
Feel free to give us a call or send us a message below.
(800) 930-5159
Support@healthtree.org
Subscribe to the weekly "HealthTree Community for AML Newsletter" for AML news, life with AML stories, AML clinical trials, AML 101 articles and events with AML experts.